Autolus Therapeutics
AUTL | NASDAQ
$1.94
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.03 (+1.55%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Market Data
Market Cap $516.32M
Enterprise Value $398.2M
Beta 2.09
Average Volume 1.84M
Shares Outstanding (Diluted) 266.16M
Shares Change YoY 0.01%
Institutional Ownership 50.51%
Exchange NASDAQ
ISIN US05280R1005
Price Performance
Price Change 1M -19.2%
Price Change 3M 16.9%
Price Change 6M 45.9%
Price Change YTD 3.7%
Price Change 1Y 40.6%
Price Change 3Y -17.1%
Price Change 5Y -69.2%
1M CAGR (ann.) -3.0%
1Y CAGR (ann.) 52.8%
5Y CAGR (ann.) -22.2%
All-Time CAGR -26.6%
Valuation
PE Ratio -1.83
Forward PE N/A
PEG Ratio 0.07
Forward PEG 0.09
PS Ratio 4.40
Forward PS 2.60
PB Ratio 6.90
P/FCF Ratio -2.17
P/Adj. FCF Ratio -2.04
P/OCF Ratio -2.28
EV/Sales 3.39
EV/EBIT -1.71
EV/EBITDA -1.80
EV/FCF -1.68
Earnings Yield -54.6%
FCF Yield -46.0%
Adj. FCF Yield -49.0%
Financial Health
Net Cash $201.63M
Total Debt $83.51M
Cash & Short-Term Investments $201.63M
Total Assets $493.23M
Current Ratio 4.89
Quick Ratio 4.40
Debt / Equity Ratio 1.12
Debt / EBITDA -0.38
Debt / FCF -0.35
OCF / Debt -2.70
Interest Coverage -5.25
Altman Z-Score -4.18
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 15.7%
Operating Profit Margin -210.8%
EBITDA Margin -188.7%
Net Profit Margin -238.6%
FCF Margin -202.3%
Adj. FCF Margin -215.5%
SBC / Revenue 13.2%
SBC Impact (per share) -6.5%
Returns
Return on Assets -56.8%
Return on Equity -178.6%
Return on Invested Capital -57.5%
Return on Capital Employed -58.3%
Return on Tangible Assets -59.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.3%
Revenue CAGR 5Y 108.2%
Revenue CAGR 10Y 95.2%
EPS CAGR 3Y 4.9%
EPS CAGR 5Y 16.5%
EPS CAGR 10Y 2.4%
FCF CAGR 3Y -16.1%
FCF CAGR 5Y -21.0%
FCF CAGR 10Y -23.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y 29.6%
Revenue Growth Next 3Y 58.0%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $8.87
Price Target Upside 357.2%
Cash Flow
Operating Cash Flow $-225.61M
Free Cash Flow $-237.45M
Adj. Free Cash Flow $-252.89M
FCF Per Share -$0.89
OCF Per Share -$0.85
OCF/S Ratio -192.2%
Income Statement
Revenue $117.35M
Gross Profit $18.38M
Operating Income $-247.33M
EBITDA $-221.4M
Net Income $-280.03M
EPS (Diluted) -$1.06
Revenue / Employee $156.06K
Profit / Employee $-372.38K
Employees 752
Add to Watchlist
Select watchlists to add or remove AUTL